Aprea Therapeutics Inc (APRE)

Aprea Therapeutics Inc (APRE) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $7.5M; returns 1 day -4.4%, 1 week -11.4%, 1 year -65.9%.

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that target DNA damage response (DDR) pathways. Their approach aims to exploit vulnerabilities associated with cancer cell mutations to kill tumors while minimizing damage to healthy cells.

Groups APRE belongs to

• Healthcare
• Biotechnology
• Clinical Stage Biotech
• Oncology
• Cancer Therapeutics
• Biopharmaceutical
• Clinical Stage
• Life Sciences
• Pharmaceuticals
• R&D

APRE financial model: income statement, cash flow and balance sheet